Fig. 6
From: Recent advances in exosome-mediated nucleic acid delivery for cancer therapy
A RNA nanoparticle and RNA nanoparticles-modified exosome [143]. B Exosomes co-delivery chemotherapy drugs oxaliplatin (OXA) and nucleic acid drugs gal-9 siRNA to enhancing immunotherapy and reprogramming tumor microenvironment (TME) [100]. C cRGD-modified exosome with high siFGL1 and siTGF-β1 loading efficiency to realize the co-silence of FGL1 and TGF-β1 to to block immune checkpoints and simultaneously regulate TME [150]